Market Research Life Sciences Market Research Medical Devices Market Research Needles, Syringes, IV Access Market Research

Global Autoinjectors Market, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), By Design (Standardized v/s Customized), By Product (Prefilled v/s Fillable), By Technology (Automated v/s Manual), By Type (Disposable v/s

Best Price Guarantee Length Publisher Published Date SKU
from $4,900 115 Pages TechSci Research July, 2022 TCSI17300411
Best Price Guarantee
Price from $4,900
Length 115 Pages
Publisher TechSci Research
Published Date July, 2022
SKU TCSI17300411

Global Autoinjectors Market, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), By Design (Standardized v/s Customized), By Product (Prefilled v/s Fillable), By Technology (Automated v/s Manual), By Type (Disposable v/s Reusable), By Route of Administration (Intravenous v/s Subcutaneous), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings), By Region, Competition Forecast & Opportunities, 2027

The global autoinjectors market is expected to witness a growth of robust CAGR in the forecast period, 2023-2027. Factors such as increased incidence of anaphylaxis and availability of generic autoinjectors in the market are primarily driving the demand for the global autoinjectors market. The rise in the prevalence of targeted therapies and the shift in preference of consumers for self-administration of drugs are expected to further fuel the market demand in the forecast period. Also, the massive government support and favorable reimbursements and advancements in the healthcare industry are expected to create numerous growth opportunities for the market players in the next five years.

The global autoinjectors market is segmented into therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitive landscape. Based on therapy, the market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. The rheumatoid arthritis segment is expected to capture the highest market share in the forecast period, 2023-2027. The high prevalence of rheumatoid arthritis worldwide is expected to drive the demand for autoinjectors across the globe.

The major market players in the global autoinjectors market are Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, and Medeca Pharma AB.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F–2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global autoinjectors market from 2017 to 2021.
  • To estimate and forecast the market size of global autoinjectors market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global autoinjectors market based on therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global autoinjectors market.
  • To identify drivers and challenges for global autoinjectors market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoinjectors market.
  • To identify and analyze the profile of leading players operating in global autoinjectors market.
  • To identify key sustainable strategies adopted by market players in global autoinjectors market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global autoinjectors market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of autoinjectors and other stakeholders
  • Organizations, forums, and alliances related to autoinjectors market
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global autoinjectors market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
  • Global Autoinjectors Market, By Therapy:
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Others
  • Global Autoinjectors Market, By Design:
  • Standardized
  • Customized
  • Global Autoinjectors Market, By Product:
  • Prefilled
  • Fillable
  • Global Autoinjectors Market, By Technology:
  • Automated
  • Manual
  • Global Autoinjectors Market, By Type:
  • Disposable
  • Reusable
  • Global Autoinjectors Market, By Route of Administrations:
  • Intravenous
  • Subcutaneous
  • Global Autoinjectors Market, By End User:
  • Hospitals & Clinics
  • Ambulatory Care Settings
  • Home Care Settings
  • Global Autoinjectors Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoinjectors market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Impact of COVID-19 on Global Autoinjectors Market
6. Global Autoinjectors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others)
6.2.2. By Design (Standardized v/s Customized)
6.2.3. By Product (Prefilled v/s Fillable)
6.2.4. By Technology (Automated v/s Manual)
6.2.5. By Type (Disposable v/s Reusable)
6.2.6. By Route of Administration (Intravenous v/s Subcutaneous)
6.2.7. By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings)
6.2.8. By Company (2021)
6.2.9. By Region
6.3. Product Market Map
7. Asia-Pacific Autoinjectors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Design
7.2.3. By Product
7.2.4. By Technology
7.2.5. By Type
7.2.6. By Route of Administration
7.2.7. By End User
7.2.8. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Autoinjectors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Design
7.3.1.2.3. By Product
7.3.1.2.4. By Technology
7.3.1.2.5. By Type
7.3.1.2.6. By Route of Administration
7.3.1.2.7. By End User
7.3.2. India Autoinjectors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Design
7.3.2.2.3. By Product
7.3.2.2.4. By Technology
7.3.2.2.5. By Type
7.3.2.2.6. By Route of Administration
7.3.2.2.7. By End User
7.3.3. South Korea Autoinjectors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Design
7.3.3.2.3. By Product
7.3.3.2.4. By Technology
7.3.3.2.5. By Type
7.3.3.2.6. By Route of Administration
7.3.3.2.7. By End User
7.3.4. Japan Autoinjectors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy
7.3.4.2.2. By Design
7.3.4.2.3. By Product
7.3.4.2.4. By Technology
7.3.4.2.5. By Type
7.3.4.2.6. By Route of Administration
7.3.4.2.7. By End User
7.3.5. Australia Autoinjectors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy
7.3.5.2.2. By Design
7.3.5.2.3. By Product
7.3.5.2.4. By Technology
7.3.5.2.5. By Type
7.3.5.2.6. By Route of Administration
7.3.5.2.7. By End User
8. Europe Autoinjectors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Design
8.2.3. By Product
8.2.4. By Technology
8.2.5. By Type
8.2.6. By Route of Administration
8.2.7. By End User
8.2.8. By Country
8.3. Europe: Country Analysis
8.3.1. France Autoinjectors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Design
8.3.1.2.3. By Product
8.3.1.2.4. By Technology
8.3.1.2.5. By Type
8.3.1.2.6. By Route of Administration
8.3.1.2.7. By End User
8.3.2. Germany Autoinjectors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Design
8.3.2.2.3. By Product
8.3.2.2.4. By Technology
8.3.2.2.5. By Type
8.3.2.2.6. By Route of Administration
8.3.2.2.7. By End User
8.3.3. United Kingdom Autoinjectors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Design
8.3.3.2.3. By Product
8.3.3.2.4. By Technology
8.3.3.2.5. By Type
8.3.3.2.6. By Route of Administration
8.3.3.2.7. By End User
8.3.4. Italy Autoinjectors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Design
8.3.4.2.3. By Product
8.3.4.2.4. By Technology
8.3.4.2.5. By Type
8.3.4.2.6. By Route of Administration
8.3.4.2.7. By End User
8.3.5. Spain Autoinjectors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Design
8.3.5.2.3. By Product
8.3.5.2.4. By Technology
8.3.5.2.5. By Type
8.3.5.2.6. By Route of Administration
8.3.5.2.7. By End User
9. North America Autoinjectors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Design
9.2.3. By Product
9.2.4. By Technology
9.2.5. By Type
9.2.6. By Route of Administration
9.2.7. By End User
9.2.8. By Country
9.3. North America: Country Analysis
9.3.1. United States Autoinjectors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Design
9.3.1.2.3. By Product
9.3.1.2.4. By Technology
9.3.1.2.5. By Type
9.3.1.2.6. By Route of Administration
9.3.1.2.7. By End User
9.3.2. Mexico Autoinjectors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Design
9.3.2.2.3. By Product
9.3.2.2.4. By Technology
9.3.2.2.5. By Type
9.3.2.2.6. By Route of Administration
9.3.2.2.7. By End User
9.3.3. Canada Autoinjectors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Design
9.3.3.2.3. By Product
9.3.3.2.4. By Technology
9.3.3.2.5. By Type
9.3.3.2.6. By Route of Administration
9.3.3.2.7. By End User
10. South America Autoinjectors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Design
10.2.3. By Product
10.2.4. By Technology
10.2.5. By Type
10.2.6. By Route of Administration
10.2.7. By End User
10.2.8. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Autoinjectors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Design
10.3.1.2.3. By Product
10.3.1.2.4. By Technology
10.3.1.2.5. By Type
10.3.1.2.6. By Route of Administration
10.3.1.2.7. By End User
10.3.2. Argentina Autoinjectors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Design
10.3.2.2.3. By Product
10.3.2.2.4. By Technology
10.3.2.2.5. By Type
10.3.2.2.6. By Route of Administration
10.3.2.2.7. By End User
10.3.3. Colombia Autoinjectors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Design
10.3.3.2.3. By Product
10.3.3.2.4. By Technology
10.3.3.2.5. By Type
10.3.3.2.6. By Route of Administration
10.3.3.2.7. By End User
11. Middle East and Africa Autoinjectors Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Design
11.2.3. By Product
11.2.4. By Technology
11.2.5. By Type
11.2.6. By Route of Administration
11.2.7. By End User
11.2.8. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Autoinjectors Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Design
11.3.1.2.3. By Product
11.3.1.2.4. By Technology
11.3.1.2.5. By Type
11.3.1.2.6. By Route of Administration
11.3.1.2.7. By End User
11.3.2. Saudi Arabia Autoinjectors Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Design
11.3.2.2.3. By Product
11.3.2.2.4. By Technology
11.3.2.2.5. By Type
11.3.2.2.6. By Route of Administration
11.3.2.2.7. By End User
11.3.3. UAE Autoinjectors Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Design
11.3.3.2.3. By Product
11.3.3.2.4. By Technology
11.3.3.2.5. By Type
11.3.3.2.6. By Route of Administration
11.3.3.2.7. By End User
11.3.4. Kuwait Autoinjectors Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Therapy
11.3.4.2.2. By Design
11.3.4.2.3. By Product
11.3.4.2.4. By Technology
11.3.4.2.5. By Type
11.3.4.2.6. By Route of Administration
11.3.4.2.7. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Mylan N.V.
14.2. AbbVie Inc.
14.3. Eli Lilly and Company
14.4. Ypsomed Holding AG
14.5. Amgen Inc.
14.6. Becton, Dickinson, and Company
14.7. GlaxoSmithKline plc
14.8. Johnson & Johnson International, Inc.
14.9. Teva Pharmaceutical Industries Ltd
14.10. Antares Pharma, Inc.
14.11. Merck KGaA
14.12. F. Hoffmann-LA Roche
14.13. Bayer AG
14.14. Bristol-Myers Squibb Company
14.15. Medeca Pharma AB
15. Strategic Recommendations

$4,900
$5,900
$8,900

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings